gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
Published 11 years ago • 285 plays • Length 5:11Download video MP4
Download video MP3
Similar videos
-
7:41
gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
4:30
gracecast-117_lung-cancer_asco 2012 lc highlights: dr. neal on molecular targets in squamous nsclc
-
4:51
gracecast-116_lung-cancer_asco 2012 lc highlights: dr. neal on select trial of tarceva (erlotinib)
-
5:58
gracecastuc-017_lung_a promising option for people with the most common lung cancer mutation?
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
5:27
gracecast-144_lung_highlights in lung cancer, 2013: mek inhibitors for kras mutation-positive nsclc
-
8:38
gracecast-109_lung-cancer_asco 2012 lung cancer highlights: dr. mark socinski on paramount trial
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
18:51
gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
-
6:38
asco lc highlights, pt 6: benefit of chemotherapy vs. egfr inhibitor therapy in second line
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
13:05
gracecast-009_lung-cancer_the abc's of bac
-
14:17
gracecast-032_lung-cancer_intro to first line nsclc treatment
-
15:43
gracecast-023_lung-cancer_george simon on nsclc variables / treatment